Results 201 to 210 of about 301,139 (266)

TOLLIP Inhibits Psoriasis Progression via Suppressing PKM2‐Mediated Glycolysis in Keratinocytes

open access: yesAdvanced Science, EarlyView.
In this study, we identify TOLLIP as a critical regulator of psoriasis pathogenesis through its modulation of glycolytic metabolism. Our findings establish the TOLLIP‐PKM2‐glycolysis axis as a key mechanism linking metabolic reprogramming to psoriasis pathogenesis, and propose TOLLIP as a promising therapeutic target.
Xiuhuan Jiang   +11 more
wiley   +1 more source

Polyfunctional antibody signature defines protection in Andes hantavirus survival. [PDF]

open access: yesFront Immunol
Bravo F   +18 more
europepmc   +1 more source

Chronic spontaneous urticaria treatments and purinergic signaling: a therapeutic possibility. [PDF]

open access: yesJ Mol Med (Berl)
Fontana M   +5 more
europepmc   +1 more source

Sialic Acids in Kidney Disease: Immune Regulation, Complement Activation and Glomerular Injury. [PDF]

open access: yesAntioxidants (Basel)
Spennacchio A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy